LB Pharmaceuticals Inc Common Stock is a publicly traded company on NASDAQ, with a market cap of $483.8M. As of Q3 2025, 89% of shares are held by 53 institutional investors, with Deep Track Capital, LP as the largest holder at 14.94%.
Overview of institutional ownership in LBRX as of Q3 2025 with a market cap of $354.4M
Based on market cap of $354.4M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in LBRX as of Q3 2025
| Institution | Position Value |
|---|---|
Deep Track Capital, LP Hedge Fund•Long/Short | $52.9M 1.50% of portfolio |
RA CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | $28.1M 0.35% of portfolio |
TCG Crossover Management, LLC Venture Capital | $27.6M 1.38% of portfolio |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | $23.7M 1.16% of portfolio |
Logos Global Management LP Hedge Fund•Long/Short | $17.8M 1.81% of portfolio |
JPMORGAN CHASE & CO Institution | $16.3M 0.00% of portfolio |
B BlackRock, Inc. Institution | $15.4M 0.00% of portfolio |
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | $15.3M 0.03% of portfolio |
Vivo Capital, LLC Venture Capital | $12.6M 1.02% of portfolio |
JENNISON ASSOCIATES LLC Long Only Manager | $11.7M 0.01% of portfolio |
Institutional buying and selling activity for LBRX in Q3 2025
| Institution | Net Bought |
|---|---|
Deep Track Capital, LP Hedge Fund•Long/Short | +$52.9M +3.4M shares |
RA CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | +$28.1M +1.8M shares |
TCG Crossover Management, LLC Venture Capital | +$27.6M +1.7M shares |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | +$23.7M +1.5M shares |
Logos Global Management LP Hedge Fund•Long/Short | +$17.8M +1.1M shares |
JPMORGAN CHASE & CO Institution | +$16.3M +1.0M shares |
B BlackRock, Inc. Institution | +$15.4M +975.0K shares |
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | +$15.3M +968.3K shares |
Vivo Capital, LLC Venture Capital | +$12.6M +800.0K shares |
JENNISON ASSOCIATES LLC Long Only Manager | +$11.7M +739.0K shares |
| Institution | Net Sold | |
|---|---|---|
| No sellers found | ||
Institutions that initiated new positions or completely exited LBRX in Q3 2025
| Institution | Position Value |
|---|---|
Deep Track Capital, LP Hedge Fund•Long/Short | $52.9M 3.4M shares |
RA CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | $28.1M 1.8M shares |
TCG Crossover Management, LLC Venture Capital | $27.6M 1.7M shares |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | $23.7M 1.5M shares |
Logos Global Management LP Hedge Fund•Long/Short | $17.8M 1.1M shares |
JPMORGAN CHASE & CO Institution | $16.3M 1.0M shares |
B BlackRock, Inc. Institution | $15.4M 975.0K shares |
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | $15.3M 968.3K shares |
Vivo Capital, LLC Venture Capital | $12.6M 800.0K shares |
JENNISON ASSOCIATES LLC Long Only Manager | $11.7M 739.0K shares |
| Institution | Previous Position |
|---|---|
| No exited positions found | |
Institutions with the largest Call and Put options positions in LBRX as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with LBRX as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
N Nan Fung Group Holdings Ltd Institution | 8.73% $4.7M |
Logos Global Management LP Hedge Fund•Long/Short | 1.81% $17.8M |
Deep Track Capital, LP Hedge Fund•Long/Short | 1.50% $52.9M |
TCG Crossover Management, LLC Venture Capital | 1.38% $27.6M |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | 1.16% $23.7M |
Vivo Capital, LLC Venture Capital | 1.02% $12.6M |
N Nantahala Capital Management, LLC Hedge Fund•Multi-Strategy | 0.66% $10.7M |
L Longwood Capital Partners LLC Institution | 0.49% $473.7K |
Boxer Capital Management, LLC Hedge Fund•Long/Short | 0.36% $1.1M |
RA CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | 0.35% $28.1M |
Discover hedge funds investing in LBRX

| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $179.9M | 9.82% | |
Biotechnology Healthcare | $138.9M | 7.59% | |
Medical - Instruments & Supplies Healthcare | $124.6M | 6.81% |
We use cookies for analytics. See our Privacy and Cookie Policy.